Skip to main content

Eli Lilly & Co

LLY
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000059478

In the last 90 days, Eli Lilly & Co insiders filed 0 open-market purchases and 3 sales; 4,643 institutions reported holding it in 13F filings for Q2 2026, worth $942.7B in total; 4 superinvestors hold it, including ARK Invest and Soros Fund Management.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Eli Lilly & Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
3 insiders, $16.0M in total
Insiders trading
3
Net value
−$16.0M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Eli Lilly & Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Eli Lilly & Co
NameTitleLast reported holdingLast filingFilings, past year
Sulzberger GabrielleDirector3,012Sep 22, 202612
Luciano Juan RDirector16,957Sep 22, 202612
Fyrwald J ErikDirector75,536Sep 22, 202612
Alvarez RalphDirector55,838Sep 22, 202612
Seymour MelissaEVP, Global Quality1,038Sep 11, 20262
Hernandez EdgardoEVP & Pres., Mfg. Operations46,083Sep 4, 20263
Dozier EricEVP, Chief People Officer14,239Sep 4, 20264
Jonsson PatrikEVP & President, LLY Int'l54,147Aug 18, 20263
Zakrowski Donald ASVP, Finance, & CAO1,526Aug 11, 20264
Hakim AnatEVP, GC & Secretary11,875IndirectAug 10, 20263
Yuffa IlyaEVP&Pres, LLY USA&Global Capab29,804Jun 11, 20263
Lilly Endowment IncOther: Former 10% Shareholder91,881,150May 7, 202634
Montarce LucasEVP & CFO16,258Feb 18, 20262
Custer Kenneth L.EVP & President, Card Met Hlth10,141Feb 18, 20262
Brown Adrienne SEVP, President LLY Imm5,142Feb 18, 20262
Rau DiogoEVP & CIDO26,397Feb 12, 20262
Ricks David APresident, Chair, and CEO571,715Feb 11, 20263
Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD26,627Feb 11, 20262
Skovronsky DanielEVP, CS&PO & Pres. LRL160,072Feb 11, 20263
Hedley Mary LynneDirector2,253Dec 16, 20253
Moeller Jon RDirector304Nov 18, 20251
Baicker KatherineDirector23,503Nov 18, 20251
Kaelin William G JrDirector21,837Nov 18, 20251
Jackson JamereDirector9,635Nov 18, 20251
Johnson Kimberly HDirector3,265Nov 18, 20251
White Anne E.EVP & Pres, Lilly Neuroscience74,210Feb 12, 20250
Walker KarenDirector6,249Nov 20, 20240
Norton JohnaEVP, Global Quality25,428Jun 3, 20240
Ashkenazi AnatEVP & CFO42,330Feb 14, 20240
Weems AlonzoEVP, ERM & CECO7,951Feb 14, 20240
Runge Marschall SDirector16,593Nov 21, 20230
Tai Jackson PDirector63,524Apr 19, 20230
Pusey Leigh AnnEVP, Corp. Affairs & Comm.31,641Feb 14, 20230
Mason Michael BEVP & Pres., Lilly Diabetes39,284Feb 14, 20230
Fry Stephen FSVP, HR & Diversity152,631Feb 11, 20220
Eskew Michael LDirector45,080Nov 17, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 17, 2024 (view filing)Jun 143 daysLilly Endowment Inc10% OwnerSSale−15.0K$882.47−$13.3M0.0%97.8M after2 lots
Jun 18, 2024 (view filing)Jun 171 dayLilly Endowment Inc10% OwnerSSale−195.0K$885.91−$172.7M−0.2%97.6M after11 lots
Jun 21, 2024 (view filing)Jun 201 dayLilly Endowment Inc10% OwnerSSale−9.67K$902.67−$8.73M0.0%97.6M after3 lots
Jun 25, 2024 (view filing)Jun 241 dayLilly Endowment Inc10% OwnerSSale−17.2K$902.38−$15.5M0.0%97.6M after2 lots
Jun 26, 2024 (view filing)Jun 251 dayLilly Endowment Inc10% OwnerSSale−188.1K$903.82−$170.0M−0.2%97.4M after8 lots
Jul 1, 2024 (view filing)Jun 283 daysLilly Endowment Inc10% OwnerSSale−1.44K$915.02−$1.32M0.0%97.4M after
Jul 2, 2024 (view filing)Jul 11 dayLilly Endowment Inc10% OwnerSSale−58.7K$915.26−$53.8M−0.1%97.3M after2 lots
Jul 3, 2024 (view filing)Jul 3Same dayLilly Endowment Inc10% OwnerSSale−8.85K$915.31−$8.10M0.0%97.3M after3 lots
Jul 8, 2024 (view filing)Jul 53 daysLilly Endowment Inc10% OwnerSSale−52.4K$915.18−$47.9M−0.1%97.2M after2 lots
Jul 9, 2024 (view filing)Jul 81 dayLilly Endowment Inc10% OwnerSSale−93.6K$918.64−$86.0M−0.1%97.2M after13 lots
Jul 11, 2024 (view filing)Jul 101 dayLilly Endowment Inc10% OwnerSSale−210.0K$939.82−$197.4M−0.2%96.9M after9 lots
Aug 23, 2024 (view filing)Aug 221 dayLilly Endowment Inc10% OwnerSSale−3.20K$966.33−$3.09M0.0%96.9M after2 lots
Aug 26, 2024 (view filing)Aug 26Same dayZakrowski Donald ASVP, Finance, & CAOSSale−750$950.00−$712.5K−10.5%6.38K after10b5-1
Aug 28, 2024 (view filing)Aug 271 dayLilly Endowment Inc10% OwnerSSale−24.6K$968.46−$23.8M0.0%96.9M after7 lots
Sep 4, 2024 (view filing)Sep 31 dayLilly Endowment Inc10% OwnerSSale−24.1K$966.69−$23.3M0.0%96.9M after4 lots
Nov 8, 2024 (view filing)Nov 8Same dayZakrowski Donald ASVP, Finance, & CAOSSale−900$803.38−$723.0K−14.1%5.48K after10b5-1
Feb 7, 2025 (view filing)Feb 61 dayLilly Endowment Inc10% OwnerSSale−210.0K$874.13−$183.6M−0.2%96.7M after22 lots
Feb 12, 2025 (view filing)Feb 102 daysSkovronsky DanielEVP, CSO & Pres. LRL & LLY ImmSSale−5.00K$863.21−$4.32M−4.1%117.9K after3 lots
Feb 14, 2025 (view filing)Feb 131 dayLilly Endowment Inc10% OwnerSSale−35.4K$879.52−$31.2M0.0%96.6M after7 lots
Feb 20, 2025 (view filing)Feb 191 dayLilly Endowment Inc10% OwnerSSale−9.98K$878.44−$8.77M0.0%96.6M after4 lots
Feb 21, 2025 (view filing)Feb 201 dayLilly Endowment Inc10% OwnerSSale−14.7K$878.00−$12.9M0.0%96.6M after4 lots
Feb 24, 2025 (view filing)Feb 213 daysLilly Endowment Inc10% OwnerSSale−99.5K$882.70−$87.8M−0.1%96.5M after17 lots
Feb 25, 2025 (view filing)Feb 241 dayLilly Endowment Inc10% OwnerSSale−60.4K$27,282.83−$1.65B−0.1%96.5M after15 lotsPrice outlier
Feb 26, 2025 (view filing)Feb 251 dayLilly Endowment Inc10% OwnerSSale−225.0K$903.07−$203.2M−0.2%96.2M after12 lots
Mar 4, 2025 (view filing)Mar 31 dayLilly Endowment Inc10% OwnerSSale−220.0K$928.76−$204.3M−0.2%96.0M after13 lots
Mar 13, 2025 (view filing)Mar 13Same dayZakrowski Donald ASVP, Finance, & CAOSSale−1.00K$818.24−$818.2K−14.6%5.84K after10b5-1
May 15, 2025 (view filing)May 141 dayYuffa IlyaEVP & President, LLY Int'lSSale−1.25K$749.24−$936.5K−4.3%27.5K after10b5-1
May 27, 2025 (view filing)May 27Same dayZakrowski Donald ASVP, Finance, & CAOSSale−1.00K$716.41−$716.4K−17.1%4.84K after10b5-1
Jul 25, 2025 (view filing)Jul 241 dayLilly Endowment Inc10% OwnerSSale−280.0K$805.07−$225.4M−0.3%95.7M after6 lots
Aug 8, 2025 (view filing)Aug 8Same dayJackson JamereDirectorPPurchase+200$639.56+$127.9K+2.2%9.40K after
Aug 12, 2025 (view filing)Aug 111 dayYuffa IlyaEVP&Pres, LLY USA&Global CapabSSale−1.25K$627.01−$783.8K−4.5%26.3K after10b5-1
Aug 12, 2025 (view filing)Aug 12Same dayFyrwald J ErikDirectorPPurchase+1.56K$642.33+$1.01M+2.1%74.6K after2 lots
Aug 12, 2025 (view filing)Aug 12Same daySulzberger GabrielleDirectorPPurchase+117$641.18+$75.0K+4.5%2.70K after
Aug 12, 2025 (view filing)Aug 12Same daySkovronsky DanielEVP, CSO & Pres. LRL & LLY ImmPPurchase+1.00K$634.41+$634.4K+0.7%137.7K after
Aug 12, 2025 (view filing)Aug 12Same dayRicks David APresident, Chair, and CEOPPurchase+1.63K$644.77+$1.05M+0.3%546.6K after
Aug 13, 2025 (view filing)Aug 13Same dayVan Naarden JacobEVP & Pres., Lilly OncologyPPurchase+1.00K$647.36+$647.4K+5.1%20.6K after
Aug 14, 2025 (view filing)Aug 131 dayAlvarez RalphDirectorPPurchase+758$660.25+$500.5KNew position758 after
Aug 15, 2025 (view filing)Aug 15Same dayMontarce LucasEVP & CFOPPurchase+715$691.79+$494.6K+5.1%14.7K after
Aug 28, 2025 (view filing)Aug 28Same dayZakrowski Donald ASVP, Finance, & CAOSSale−1.00K$734.93−$734.9K−20.7%3.84K after10b5-1
Sep 19, 2025 (view filing)Sep 181 dayLilly Endowment Inc10% OwnerSSale−106.6K$764.65−$81.5M−0.1%95.6M after5 lots
Sep 22, 2025 (view filing)Sep 193 daysLilly Endowment Inc10% OwnerSSale−23.7K$763.09−$18.1M0.0%95.6M after2 lots
Oct 1, 2025 (view filing)Sep 301 dayLilly Endowment Inc10% OwnerSSale−113.7K$763.40−$86.8M−0.1%95.5M after4 lots
Oct 2, 2025 (view filing)Oct 11 dayLilly Endowment Inc10% OwnerSSale−135.2K$794.15−$107.4M−0.1%95.4M after30 lots
Oct 2, 2025 (view filing)Oct 11 dayLilly Endowment Inc10% OwnerSSale−215.8K$821.47−$177.3M−0.2%95.1M after25 lots
Oct 3, 2025 (view filing)Oct 21 dayLilly Endowment Inc10% OwnerSSale−112.6K$821.55−$92.5M−0.1%95.0M after9 lots
Oct 6, 2025 (view filing)Oct 33 daysLilly Endowment Inc10% OwnerSSale−192.4K$837.93−$161.2M−0.2%94.8M after25 lots
Oct 7, 2025 (view filing)Oct 61 dayLilly Endowment Inc10% OwnerSSale−161.2K$850.22−$137.0M−0.2%94.7M after8 lots
Oct 8, 2025 (view filing)Oct 71 dayLilly Endowment Inc10% OwnerSSale−26.8K$848.01−$22.7M0.0%94.6M after
Oct 9, 2025 (view filing)Oct 81 dayLilly Endowment Inc10% OwnerSSale−101.4K$850.28−$86.2M−0.1%94.5M after8 lots
Oct 10, 2025 (view filing)Oct 91 dayLilly Endowment Inc10% OwnerSSale−10.6K$852.49−$9.04M0.0%94.5M after8 lots